Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hib Elimination in Alaska Native Villages
NCT00153556Phase 4Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Sep 2001
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
Phase 4, open-label trial of haemophilus influenzae type b vaccine in Haemophilus influenzae type b infection (Hib) (2 arms), sponsored by Centers for Disease Control and Prevention. Primary endpoint: Change in community-wide oropharyngeal Hib colonization at 1 year. Started Sep 2001; status: completed.
02
Drugs
haemophilus influenzae type b vaccine
03
Conditions
Haemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT00153556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00153556.